Oxford BioDynamics (LSE:OBD) Total Stockholders Equity : £4.36 Mil (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics Total Stockholders Equity?

Oxford BioDynamics's Total Stockholders Equity for the quarter that ended in Sep. 2024 was £4.36 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Oxford BioDynamics's Book Value per Share for the quarter that ended in Sep. 2024 was £0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Oxford BioDynamics's Debt-to-Equity for the quarter that ended in Sep. 2024 was 1.32.

Oxford BioDynamics Total Stockholders Equity Historical Data

The historical data trend for Oxford BioDynamics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Total Stockholders Equity Chart

Oxford BioDynamics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Total Stockholders Equity

Get a 7-Day Free Trial

13.14

6.68

2.59

6.06

4.36

Oxford BioDynamics Semi-Annual Data
	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															2.59	6.71	6.06	1.62	4.36

Oxford BioDynamics (LSE:OBD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Oxford BioDynamics's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4.358	-	0)	/	311.856
	=	0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Oxford BioDynamics's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.046	+	4.694)	/	4.358
	=	1.32

Oxford BioDynamics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Oxford BioDynamics PLC (LSE:OBD) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

OXBOF:USA LMQ:Germany

Address

John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.

Oxford BioDynamics Headlines

No Headlines